Arrhythmogenic Cardiomyopathy and Biomarkers: A Promising Perspective? [PDF]
Barocelli F +13 more
europepmc +1 more source
Arrhythmogenic Cardiomyopathy Versus Viral Myocarditis in a Professional Athlete. [PDF]
DiCaro MV, Martinez MW, Danielian A.
europepmc +1 more source
Decreasing Microtubule Detyrosination Improves Cardiac Mechanics and Sodium Channel Function in Arrhythmogenic Cardiomyopathy. [PDF]
Nasilli G +12 more
europepmc +1 more source
Arrhythmogenic Cardiomyopathy: Exercise and Divergent Phenotypes in a Family With a Pathogenic PKP2 Variant. [PDF]
Zhubrina E +5 more
europepmc +1 more source
Circulating microRNA dysregulation in hypertrophic cardiomyopathy, arrhythmogenic cardiomyopathy, and dilated cardiomyopathy: a systematic review. [PDF]
Léger L +7 more
europepmc +1 more source
Transvenous and subcutaneous implantable cardioverter-defibrillator in arrhythmogenic cardiomyopathy: insights from a single-centre experience. [PDF]
Migliore F +15 more
europepmc +1 more source
Arrhythmogenic Cardiomyopathy Diagnosed Late in a Master Recreational Endurance Athlete. [PDF]
Gardikioti V +9 more
europepmc +1 more source
Borderline Arrhythmogenic Cardiomyopathy in an Athlete: Exercise Testing May Support Clinical Decision-Making. [PDF]
Wernhart S +3 more
europepmc +1 more source
Tackling non-canonical splicing in arrhythmogenic cardiomyopathy to reduce the uncertain significance variants burden. [PDF]
Celeghin R +7 more
europepmc +1 more source
FASN-mediated <i>de novo</i> lipogenesis promotes ceramide accumulation and myocardial damage in arrhythmogenic cardiomyopathy. [PDF]
Liu Z +10 more
europepmc +1 more source

